Gabriella Farina

3.0k total citations · 1 hit paper
65 papers, 1.8k citations indexed

About

Gabriella Farina is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gabriella Farina has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Gabriella Farina's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Treatment and Pharmacology (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Gabriella Farina is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Treatment and Pharmacology (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Gabriella Farina collaborates with scholars based in Italy, United States and Japan. Gabriella Farina's co-authors include Marina Chiara Garassino, A. Scanni, Valter Torri, Monica Ganzinelli, Mirko Marabese, Massimo Broggini, M. Tomirotti, Nicla La Verde, Calogero Lauricella and Flavia Longo and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Gabriella Farina

62 papers receiving 1.7k citations

Hit Papers

Erlotinib versus docetaxe... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
    2013 376 citations Marina Chiara Garassino, Olga Martelli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriella Farina Italy 24 1.0k 785 293 219 217 65 1.8k
Nurullah Zengin Türkiye 21 787 0.8× 479 0.6× 187 0.6× 300 1.4× 175 0.8× 160 1.5k
Xiaolei Zhu China 14 830 0.8× 678 0.9× 604 2.1× 156 0.7× 201 0.9× 35 2.1k
Ahmet Bılıcı Türkiye 21 853 0.8× 655 0.8× 248 0.8× 597 2.7× 297 1.4× 173 1.9k
Sameena Iqbal United Kingdom 24 572 0.6× 224 0.3× 337 1.2× 220 1.0× 108 0.5× 65 2.0k
Richard Gregg Canada 18 732 0.7× 510 0.6× 320 1.1× 221 1.0× 70 0.3× 37 1.5k
N. Simon Tchekmedyian United States 27 1.5k 1.5× 625 0.8× 319 1.1× 359 1.6× 243 1.1× 55 2.6k
Timothy F. Donahue United States 20 453 0.4× 1.1k 1.4× 180 0.6× 571 2.6× 164 0.8× 81 1.8k
Jamey Skillings Canada 18 1.3k 1.2× 514 0.7× 281 1.0× 190 0.9× 260 1.2× 40 2.1k
Mehmet Alı Nahıt Şendur Türkiye 18 825 0.8× 446 0.6× 292 1.0× 160 0.7× 158 0.7× 183 1.4k
Anthony Fields Canada 22 2.0k 2.0× 570 0.7× 290 1.0× 450 2.1× 262 1.2× 45 2.7k

Countries citing papers authored by Gabriella Farina

Since Specialization
Citations

This map shows the geographic impact of Gabriella Farina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Farina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Farina more than expected).

Fields of papers citing papers by Gabriella Farina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Farina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Farina. The network helps show where Gabriella Farina may publish in the future.

Co-authorship network of co-authors of Gabriella Farina

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Farina. A scholar is included among the top collaborators of Gabriella Farina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Farina. Gabriella Farina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noci, Sara, Tania Camboni, Eleonora Mangano, et al.. (2025). Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer. Journal for ImmunoTherapy of Cancer. 13(9). e011526–e011526.
2.
Santambrogio, Roberto, Gabriella Farina, Valentina D’Alessandro, et al.. (2020). Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques. 31(3). 266–272. 10 indexed citations
3.
4.
Verde, Nicla La, Elena Collovà, Livio Blasi, et al.. (2020). Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. Clinical Breast Cancer. 21(5). e489–e496. 7 indexed citations
5.
Caccialanza, Riccardo, et al.. (2018). To fast, or not to fast before chemotherapy, that is the question. BMC Cancer. 18(1). 337–337. 31 indexed citations
6.
Gherardi, Giorgio, Elena Biagioli, Valter Torri, et al.. (2017). The prognostic role of tumor size in early breast cancer in the era of molecular biology. PLoS ONE. 12(12). e0189127–e0189127. 24 indexed citations
7.
Caccialanza, Riccardo, Emanuele Cereda, Carmine Pinto, et al.. (2016). Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey. Nutrition. 32(9). 1028–1032. 67 indexed citations
8.
Verde, Nicla La, Elena Biagioli, Chiara Gerardi, et al.. (2016). Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study. SpringerPlus. 5(1). 114–114. 15 indexed citations
9.
Torri, Valter, et al.. (2014). Efficacy of biological agents in metastatic triple-negative breast cancer. Cancer Treatment Reviews. 40(5). 605–613. 39 indexed citations
10.
Fagnani, Daniele, V. Filipazzi, Marco Danova, et al.. (2014). Granulocyte Colony-stimulating Factors Used in Clinical Practice: PoloNord Registry-Based Cohort Italian Study. Tumori Journal. 100(5). 491–498. 12 indexed citations
11.
12.
Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male breast cancer: Clinical features and multimodal treatment in a retrospective survey analysis at Italian centers. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 3 indexed citations
13.
Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.. PubMed. 99(1). 45–50. 11 indexed citations
14.
Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male Breast Cancer: Clinical Features and Multimodal Treatment in a Retrospective Survey Analysis at Italian Centers. Tumori Journal. 99(5). 596–600. 4 indexed citations
15.
Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-Induced Anemia and Oncologist Perception on Treatment: Results of a Web-Based Survey. Tumori Journal. 99(1). 45–50. 11 indexed citations
16.
Garassino, Marina Chiara, Olga Martelli, Anna Bettini, et al.. (2012). TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR.. Journal of Clinical Oncology. 30(15_suppl). LBA7501–LBA7501. 43 indexed citations
17.
18.
Santoro, Giuseppe, Giovanbattista Capozzi, Giuseppe Caianiello, et al.. (2009). Pulmonary Artery Growth After Palliation of Congenital Heart Disease With Duct-Dependent Pulmonary Circulation. Journal of the American College of Cardiology. 54(23). 2180–2186. 80 indexed citations
19.
Garassino, Marina Chiara, Karen Borgonovo, Antônio Rossi, et al.. (2009). Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.. PubMed. 29(7). 2691–701. 27 indexed citations
20.
Farina, Gabriella, et al.. (1997). Long Term Toxicity in Adjuvant Treatment with Tamoxifen. Journal of Chemotherapy. 9(4). 300–303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nurullah Zengin Breakdown of academic impact, for papers by Xiaolei Zhu Breakdown of academic impact, for papers by Ahmet Bılıcı Breakdown of academic impact, for papers by Sameena Iqbal Breakdown of academic impact, for papers by Richard Gregg Breakdown of academic impact, for papers by N. Simon Tchekmedyian Breakdown of academic impact, for papers by Timothy F. Donahue Breakdown of academic impact, for papers by Jamey Skillings Breakdown of academic impact, for papers by Mehmet Alı Nahıt Şendur Breakdown of academic impact, for papers by Anthony Fields
Rankless by CCL
2026